The placebo effect in Parkinson’s disease

  • de la Fuente-Fernández R
  • Stoessl A
  • 2


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


The biochemical bases of the placebo effect are still incompletely known. We show here that the placebo effect in Parkinson’s disease is due, at least in part, to the release of dopamine in the striatum. We propose that the placebo effect might be related to reward mechanisms. The expectation of reward (i.e. clinical benefit) seems to be particularly relevant. According to this theory, brain dopamine release could be a common biochemical substrate for the placebo effect encountered in other medical conditions, such as pain and depression. Other neurotransmitters or neuropeptides, however, are also likely to be involved in mediating the placebo effect (e.g. opioids in pain disorders, serotonin in depression).

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • R de la Fuente-Fernández

  • A J Stoessl

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free